BCG vaccination

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Bacille Calmette-Guérin vaccination or BCG vaccination is a vaccination which been used to protest against tuberculosis (TB) for over 100 years. More recently, BCG vaccines have been found to cause more wide-ranging and positive immune system effects[1] and has been suggested as a treatment for Fibromyalgia[2] and COVID-19.[citation needed]

Theory[edit | edit source]

Evidence[edit | edit source]

Fibromyalgia clinical trial[edit | edit source]

A planned trial of three BCG vaccine doses for people with fibromyalgia was approved by the FDA but was withdrawn in 2022.[3]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Cost and availability[edit | edit source]

Notable studies[edit | edit source]

  • 2022, BCG vaccinations drive epigenetic changes to the human T cell receptor: Restored expression in type 1 diabetes[1] - (Full text)
  • 2012, Unique immunologic patterns in fibromyalgia[2] - (Full text)

News and articles[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]